(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736846 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LOX mRNA CTD PMID:22079256 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LOX mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of LOX mRNA CTD PMID:16079270 17alpha-ethynylestradiol multiple interactions ISO RGD:732343 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of LOX mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:736846 6480464 Estradiol affects the expression of LOX mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO RGD:732343 6480464 Estradiol results in increased expression of LOX mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:736846 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of LOX mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of LOX mRNA CTD PMID:20404318 , PMID:30165855 17beta-estradiol decreases expression ISO RGD:736846 6480464 Estradiol results in decreased expression of LOX mRNA CTD PMID:20106945 , PMID:21632981 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736846 6480464 Dihydrotestosterone results in increased expression of LOX mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732343 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of LOX mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732343 6480464 Tetrachlorodibenzodioxin results in increased expression of LOX mRNA CTD PMID:16922920 , PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732343 6480464 Tetrachlorodibenzodioxin affects the expression of LOX mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOX mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736846 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOX mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LOX mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732343 6480464 Tetrachlorodibenzodioxin results in decreased expression of LOX mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:732343 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:732343 6480464 Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA CTD PMID:17982090 , PMID:18200517 2-butoxyethanol decreases expression ISO RGD:732343 6480464 n-butoxyethanol results in decreased expression of LOX mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:732343 6480464 tetrabromobisphenol A results in decreased expression of LOX mRNA CTD PMID:25172293 3-methylcholanthrene decreases expression ISO RGD:732343 6480464 Methylcholanthrene results in decreased expression of LOX mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of LOX mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LOX mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:732343 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LOX mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:732343 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LOX mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:732343 6480464 Fenretinide results in increased expression of LOX mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:736846 6480464 Decitabine results in increased expression of LOX mRNA CTD PMID:17908484 5-aza-2'-deoxycytidine affects expression ISO RGD:736846 6480464 Decitabine affects the expression of LOX mRNA CTD PMID:17194187 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of LOX mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of LOX mRNA CTD PMID:19483382 , PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of LOX mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of LOX mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:736846 6480464 Aflatoxin B1 affects the expression of LOX protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:736846 6480464 Aflatoxin B1 results in decreased methylation of LOX gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736846 6480464 Aflatoxin B1 results in decreased expression of LOX mRNA CTD PMID:21632981 , PMID:21641981 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of LOX mRNA CTD PMID:16079270 all-trans-retinoic acid decreases expression ISO RGD:736846 6480464 Tretinoin results in decreased expression of LOX mRNA CTD PMID:23724009 all-trans-retinoic acid multiple interactions ISO RGD:732343 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LOX mRNA more ... CTD PMID:30951980 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of LOX mRNA CTD PMID:18355885 , PMID:19483382 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of LOX mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LOX mRNA CTD PMID:16483693 ampicillin increases expression ISO RGD:736846 6480464 Ampicillin results in increased expression of LOX mRNA CTD PMID:21632981 antirheumatic drug increases expression ISO RGD:736846 6480464 Antirheumatic Agents results in increased expression of LOX mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:736846 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LOX mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:736846 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LOX mRNA CTD PMID:32525701 arsenite(3-) increases expression ISO RGD:736846 6480464 arsenite results in increased expression of LOX mRNA CTD PMID:23974009 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of LOX mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:732343 6480464 Benzo(a)pyrene results in decreased expression of LOX mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:736846 6480464 Benzo(a)pyrene results in increased methylation of LOX exon CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:736846 6480464 Benzo(a)pyrene results in decreased methylation of LOX 5' UTR, Benzo(a)pyrene results in decreased methylation of LOX promoter CTD PMID:27901495 benzo[a]pyrene affects expression ISO RGD:732343 6480464 Benzo(a)pyrene affects the expression of LOX mRNA CTD PMID:22342234 benzo[a]pyrene decreases expression ISO RGD:736846 6480464 Benzo(a)pyrene results in decreased expression of LOX mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene increases expression ISO RGD:732343 6480464 Benzo(a)pyrene results in increased expression of LOX mRNA CTD PMID:21569818 beta-aminopropionitrile decreases activity EXP 6480464 Aminopropionitrile results in decreased activity of LOX protein CTD PMID:19524603 beta-aminopropionitrile multiple interactions ISO RGD:736846 6480464 Aminopropionitrile inhibits the reaction [cupric chloride results in increased activity of LOX protein] CTD PMID:25044713 beta-aminopropionitrile decreases activity ISO RGD:732343 6480464 Aminopropionitrile results in decreased activity of LOX protein CTD PMID:22367676 beta-aminopropionitrile decreases activity ISO RGD:736846 6480464 Aminopropionitrile results in decreased activity of LOX protein CTD PMID:16023247 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LOX mRNA CTD PMID:18164116 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of LOX mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:736846 6480464 Diethylhexyl Phthalate results in decreased expression of LOX mRNA CTD PMID:28412506 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736846 6480464 Diethylhexyl Phthalate results in increased expression of LOX mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:736846 6480464 bisphenol A results in decreased expression of LOX mRNA CTD PMID:22576693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LOX mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:732343 6480464 bisphenol A results in increased expression of LOX mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:732343 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of LOX mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:736846 6480464 bisphenol A affects the expression of LOX mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LOX mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of LOX mRNA CTD PMID:26496021 bisphenol F multiple interactions ISO RGD:732343 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LOX mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:732343 6480464 bisphenol F results in increased expression of LOX mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of LOX mRNA CTD PMID:32479839 brucine decreases expression ISO RGD:732343 6480464 brucine results in decreased expression of LOX mRNA, brucine results in decreased expression of LOX protein CTD PMID:23933019 brucine decreases expression ISO RGD:736846 6480464 brucine results in decreased expression of LOX mRNA CTD PMID:23933019 cadmium atom affects methylation EXP 6480464 Cadmium affects the methylation of LOX promoter CTD PMID:25741534 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of LOX CTD PMID:19879314 cadmium atom affects expression EXP 6480464 Cadmium affects the expression of LOX CTD PMID:25741534 cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of LOX CTD PMID:19879314 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of LOX mRNA CTD PMID:25993096 cadmium dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [cobaltous chloride promotes the reaction [HIF1A protein binds to LOX promoter]] CTD PMID:23161664 cadmium dichloride multiple interactions ISO RGD:732343 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LOX mRNA CTD PMID:19840844 calcitriol increases expression ISO RGD:736846 6480464 Calcitriol results in increased expression of LOX mRNA CTD PMID:16002434 carbon nanotube increases expression ISO RGD:732343 6480464 Nanotubes, Carbon analog results in increased expression of LOX mRNA, Nanotubes, Carbon results in increased expression of LOX mRNA CTD PMID:25554681 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of LOX mRNA CTD PMID:21216836 chloroprene increases expression ISO RGD:732343 6480464 Chloroprene results in increased expression of LOX mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of LOX mRNA CTD PMID:23125180 ciglitazone multiple interactions ISO RGD:736846 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of LOX mRNA CTD PMID:16197558 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of LOX mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:736846 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of LOX mRNA CTD PMID:20705681 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of LOX mRNA CTD PMID:19483382 clofibrate increases expression ISO RGD:732343 6480464 Clofibrate results in increased expression of LOX mRNA CTD PMID:17585979 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of LOX mRNA CTD PMID:18355885 clothianidin increases expression ISO RGD:736846 6480464 clothianidin results in increased expression of LOX mRNA CTD PMID:29044138 cobalt dichloride increases expression ISO RGD:736846 6480464 cobaltous chloride results in increased expression of LOX mRNA, cobaltous chloride results in increased expression of LOX protein CTD PMID:24614111 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of LOX mRNA CTD PMID:23161664 cobalt dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [cobaltous chloride promotes the reaction [HIF1A protein binds to LOX promoter]] more ... CTD PMID:23161664 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of LOX mRNA CTD PMID:17898221 copper atom multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX protein CTD PMID:22276220 copper atom decreases expression EXP 6480464 Copper results in decreased expression of LOX mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:732343 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOX mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX protein CTD PMID:22276220 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of LOX mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:732343 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOX mRNA CTD PMID:15467011 copper(II) chloride increases activity ISO RGD:732343 6480464 cupric chloride results in increased activity of LOX protein CTD PMID:22367676 copper(II) chloride multiple interactions ISO RGD:736846 6480464 Aminopropionitrile inhibits the reaction [cupric chloride results in increased activity of LOX protein] CTD PMID:25044713 copper(II) chloride increases activity ISO RGD:736846 6480464 cupric chloride results in increased activity of LOX protein CTD PMID:25044713 copper(II) sulfate increases expression ISO RGD:736846 6480464 Copper Sulfate results in increased expression of LOX mRNA CTD PMID:20599845 copper(II) sulfate decreases expression ISO RGD:736846 6480464 Copper Sulfate results in decreased expression of LOX mRNA CTD PMID:19549813 , PMID:20599845 crocidolite asbestos decreases expression ISO RGD:732343 6480464 Asbestos, Crocidolite results in decreased expression of LOX mRNA CTD PMID:29279043 curcumin multiple interactions ISO RGD:732343 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LOX mRNA] CTD PMID:18200517 cyclosporin A decreases expression ISO RGD:736846 6480464 Cyclosporine results in decreased expression of LOX mRNA CTD PMID:20106945 more ... cytarabine decreases expression ISO RGD:736846 6480464 Cytarabine results in decreased expression of LOX mRNA CTD PMID:21198554 DDT decreases expression EXP 6480464 DDT results in decreased expression of LOX mRNA CTD PMID:30207508 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of LOX mRNA CTD PMID:23640034 Deguelin multiple interactions ISO RGD:736846 6480464 deguelin inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] CTD PMID:22745725 desferrioxamine B multiple interactions ISO RGD:736846 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 dexamethasone increases expression ISO RGD:732343 6480464 Dexamethasone results in increased expression of LOX mRNA CTD PMID:10926554 , PMID:22733784 dextran sulfate multiple interactions ISO RGD:732343 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOX mRNA CTD PMID:29950665 diallyl trisulfide multiple interactions ISO RGD:736846 6480464 diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] CTD PMID:28574600 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LOX mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:736846 6480464 dicrotophos results in increased expression of LOX mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:736846 6480464 (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] more ... CTD PMID:22745725 more ... dioxygen multiple interactions ISO RGD:732343 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LOX mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:736846 6480464 Oxygen deficiency results in increased expression of LOX mRNA, Oxygen deficiency results in increased expression of LOX protein CTD PMID:18924134 more ... dioxygen increases activity ISO RGD:736846 6480464 Oxygen deficiency results in increased activity of LOX protein CTD PMID:25044713 dioxygen increases expression ISO RGD:732343 6480464 Oxygen deficiency results in increased expression of LOX mRNA, Oxygen deficiency results in increased expression of LOX protein CTD PMID:24614111 diuron decreases expression EXP 6480464 Diuron results in decreased expression of LOX mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:736846 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LOX mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:736846 6480464 LOX protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of LOX mRNA CTD PMID:32289291 doxorubicin increases expression ISO RGD:736846 6480464 Doxorubicin results in increased expression of LOX mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:736846 6480464 Doxorubicin results in decreased expression of LOX mRNA CTD PMID:22908232 doxorubicin multiple interactions ISO RGD:732343 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of LOX mRNA CTD PMID:21040762 doxorubicin increases expression ISO RGD:732343 6480464 Doxorubicin results in increased expression of LOX mRNA CTD PMID:21040762 doxorubicin affects expression ISO RGD:732343 6480464 Doxorubicin affects the expression of LOX mRNA CTD PMID:15033991 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LOX mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:732343 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LOX mRNA CTD PMID:30517762 ethanol increases expression ISO RGD:736846 6480464 Ethanol results in increased expression of LOX mRNA CTD PMID:23378141 ethanol multiple interactions ISO RGD:736846 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of LOX mRNA CTD PMID:23378141 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of LOX mRNA CTD PMID:30307764 flutamide increases expression EXP 6480464 Flutamide results in increased expression of LOX mRNA CTD PMID:21525395 folic acid multiple interactions ISO RGD:736846 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of LOX mRNA CTD PMID:23378141 furan increases expression EXP 6480464 furan results in increased expression of LOX mRNA CTD PMID:27387713 glycidol increases expression EXP 6480464 glycidol results in increased expression of LOX mRNA CTD PMID:24395379 hemin multiple interactions ISO RGD:736846 6480464 [Hemin results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 hydrogen peroxide affects expression ISO RGD:736846 6480464 Hydrogen Peroxide affects the expression of LOX mRNA CTD PMID:23410634 hydrogen sulfide increases expression ISO RGD:732343 6480464 Hydrogen Sulfide results in increased expression of LOX mRNA CTD PMID:31843631 imipramine affects expression EXP 6480464 Imipramine affects the expression of LOX mRNA CTD PMID:18355885 iron atom multiple interactions ISO RGD:736846 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA, [Hemin results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 iron(0) multiple interactions ISO RGD:736846 6480464 [Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA, [Hemin results in decreased abundance of Iron] which results in increased expression of LOX mRNA CTD PMID:12393473 isoprenaline increases expression ISO RGD:732343 6480464 Isoproterenol results in increased expression of LOX mRNA CTD PMID:20003209 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of LOX mRNA CTD PMID:18355885 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of LOX mRNA CTD PMID:19483382 lead(0) affects expression ISO RGD:736846 6480464 Lead affects the expression of LOX mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:736846 6480464 Lead affects the expression of LOX mRNA CTD PMID:28903495 linoleic acid multiple interactions ISO RGD:732343 6480464 FADS2 protein inhibits the reaction [Linoleic Acid results in increased activity of LOX protein], TGFB1 protein promotes the reaction [Linoleic Acid results in increased activity of LOX protein] CTD PMID:26240151 linoleic acid increases activity ISO RGD:732343 6480464 Linoleic Acid results in increased activity of LOX protein CTD PMID:26240151 losartan decreases expression EXP 6480464 Losartan results in decreased expression of LOX mRNA CTD PMID:15100363 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of LOX mRNA CTD PMID:28801915 menadione affects expression ISO RGD:736846 6480464 Vitamin K 3 affects the expression of LOX mRNA CTD PMID:23410634 metformin affects expression EXP 6480464 Metformin affects the expression of LOX mRNA CTD PMID:31324951 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of LOX mRNA CTD PMID:30467583 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of LOX mRNA CTD PMID:25972201 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of LOX mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:732343 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LOX mRNA more ... CTD PMID:19840844 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LOX mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:736846 6480464 Diethylnitrosamine results in increased expression of LOX mRNA CTD PMID:21527772 N-nitrosomorpholine affects expression EXP 6480464 N-nitrosomorpholine affects the expression of LOX mRNA CTD PMID:19716841 naphthalene increases expression ISO RGD:732343 6480464 naphthalene results in increased expression of LOX mRNA CTD PMID:18978301 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of LOX mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:732343 6480464 Nickel results in increased expression of LOX mRNA CTD PMID:12540486 nickel dichloride increases expression ISO RGD:736846 6480464 nickel chloride results in increased expression of LOX mRNA CTD PMID:17312168 , PMID:21455298 nickel sulfate increases expression ISO RGD:736846 6480464 nickel sulfate results in increased expression of LOX mRNA CTD PMID:17382205 nickel sulfate decreases expression ISO RGD:736846 6480464 nickel sulfate results in decreased expression of LOX mRNA CTD PMID:22714537 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of LOX mRNA, nitrofen results in decreased expression of LOX protein CTD PMID:25111273 okadaic acid multiple interactions ISO RGD:732343 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LOX mRNA CTD PMID:19840844 oleic acid increases activity ISO RGD:732343 6480464 Oleic Acid results in increased activity of LOX protein CTD PMID:26240151 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of LOX mRNA CTD PMID:19483382 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of LOX mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LOX mRNA CTD PMID:25729387 ozone increases expression ISO RGD:732343 6480464 Ozone results in increased expression of LOX mRNA CTD PMID:17095637 paclitaxel multiple interactions ISO RGD:736846 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of LOX mRNA CTD PMID:20705681 paracetamol affects expression ISO RGD:732343 6480464 Acetaminophen affects the expression of LOX mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LOX mRNA CTD PMID:17202762 more ... pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of LOX mRNA CTD PMID:25710175 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of LOX mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of LOX mRNA CTD PMID:16221955 , PMID:19162173 phenylmercury acetate increases expression ISO RGD:736846 6480464 Phenylmercuric Acetate results in increased expression of LOX mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736846 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LOX mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:732343 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LOX mRNA CTD PMID:19840844 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of LOX mRNA CTD PMID:19483382 potassium chromate increases expression ISO RGD:736846 6480464 potassium chromate(VI) results in increased expression of LOX mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:736846 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LOX mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:732343 6480464 Potassium Dichromate results in decreased expression of LOX mRNA CTD PMID:23608068 progesterone increases expression ISO RGD:732343 6480464 Progesterone results in increased expression of LOX mRNA CTD PMID:22238285 quercetin decreases expression ISO RGD:736846 6480464 Quercetin results in decreased expression of LOX mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:736846 6480464 Oxyquinoline results in decreased expression of LOX mRNA CTD PMID:21632981 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of LOX mRNA CTD PMID:16079270 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of LOX mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:736846 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LOX mRNA CTD PMID:27188386 semicarbazide decreases activity EXP 6480464 carbamylhydrazine results in decreased activity of LOX protein CTD PMID:19524603 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of LOX mRNA CTD PMID:15967596 silicon dioxide decreases expression ISO RGD:736846 6480464 Silicon Dioxide analog results in decreased expression of LOX mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:732343 6480464 Silver results in decreased expression of LOX mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:732343 6480464 Silver results in decreased expression of LOX mRNA CTD PMID:27131904 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of LOX mRNA CTD PMID:16414398 sodium arsenate increases expression ISO RGD:732343 6480464 sodium arsenate results in increased expression of LOX mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:736846 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LOX mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:732343 6480464 sodium arsenite results in decreased expression of LOX mRNA CTD PMID:32068019 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of LOX mRNA CTD PMID:25993096 sulforaphane decreases expression ISO RGD:732343 6480464 sulforafan results in decreased expression of LOX mRNA CTD PMID:30529165 sulindac decreases expression ISO RGD:736846 6480464 Sulindac analog results in decreased expression of LOX mRNA CTD PMID:18924134 sunitinib decreases expression ISO RGD:736846 6480464 Sunitinib results in decreased expression of LOX mRNA CTD PMID:31533062 tauroursodeoxycholic acid decreases expression EXP 6480464 tauroursodeoxycholic acid results in decreased expression of LOX mRNA CTD PMID:15885361 tert-butyl hydroperoxide affects expression ISO RGD:736846 6480464 tert-Butylhydroperoxide affects the expression of LOX mRNA CTD PMID:23410634 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of LOX mRNA CTD PMID:26496021 tetrachloromethane affects expression ISO RGD:732343 6480464 Carbon Tetrachloride affects the expression of LOX mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:732343 6480464 [Carbon Tetrachloride co-treated with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea] results in increased expression of LOX mRNA, [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LOX mRNA CTD PMID:25827057 , PMID:30517762 tetrachloromethane increases expression ISO RGD:732343 6480464 Carbon Tetrachloride results in increased expression of LOX mRNA CTD PMID:15056808 , PMID:25827057 tetrathiomolybdate(2-) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX mRNA, [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of LOX protein CTD PMID:22276220 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of LOX mRNA CTD PMID:19483382 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LOX mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:732343 6480464 titanium dioxide results in increased expression of LOX mRNA CTD PMID:27760801 titanium dioxide multiple interactions ISO RGD:732343 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOX mRNA CTD PMID:29950665 titanium dioxide decreases expression ISO RGD:732343 6480464 titanium dioxide results in decreased expression of LOX mRNA CTD PMID:23409001 toluene increases expression EXP 6480464 Toluene results in increased expression of LOX mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LOX mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of LOX mRNA CTD PMID:25729387 Trapidil multiple interactions EXP 6480464 Trapidil affects the reaction [PTH protein affects the expression of LOX mRNA] CTD PMID:18635661 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of LOX mRNA CTD PMID:21683754 trimellitic anhydride increases expression ISO RGD:732343 6480464 trimellitic anhydride results in increased expression of LOX mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of LOX mRNA CTD PMID:30589522 tris(2-butoxyethyl) phosphate affects expression ISO RGD:736846 6480464 tris(2-butoxyethyl) phosphate affects the expression of LOX mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:732343 6480464 troglitazone results in increased expression of LOX mRNA CTD PMID:28973697 urethane decreases expression ISO RGD:736846 6480464 Urethane results in decreased expression of LOX mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of LOX mRNA CTD PMID:15885361 valproic acid increases expression ISO RGD:736846 6480464 Valproic Acid results in increased expression of LOX mRNA CTD PMID:19101580 , PMID:28001369 valproic acid increases expression ISO RGD:732343 6480464 Valproic Acid results in increased expression of LOX mRNA CTD PMID:24896083 valproic acid decreases expression ISO RGD:736846 6480464 Valproic Acid results in decreased expression of LOX mRNA CTD PMID:23179753 , PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LOX mRNA CTD PMID:23034163
Gene-Chemical Interaction Annotations
